Nameer Ascandar: Outcomes After GI Bleeding in Patients with Rheumatoid Arthritis and AF on Long-Term Oral Anticoagulation
Nameer Ascandar, Internal Medicine Resident Physician at HCA Florida Sarasota Doctors Hospital, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Excited to share our second publication of the month!
This study examined outcomes after gastrointestinal bleeding in patients with rheumatoid arthritis and atrial fibrillation on long-term oral anticoagulation.
We found that patients with rheumatoid arthritis hospitalized for GI bleeding while on anticoagulation for atrial fibrillation had significantly worse in-hospital outcomes, including higher mortality and greater risk of septic shock compared to those without RA.
Interestingly, RA patients had lower rates of acute ischemic stroke and reduced need for blood transfusion, highlighting the complex balance between thrombosis and bleeding in this population.”
Title: Predictors of Mortality and In-Hospital Outcomes After Gastrointestinal Bleed in Patients With Rheumatoid Arthritis and Atrial Fibrillation on Long Term Oral Anticoagulants: A Propensity Score Matched Analysis
Authors: Nameer Ascandar, Abhinav Singh, Ian Lancaster, Shaival Thakore, Michael Schandorf-Lartey, Jeffrey P. Steinhoff
Read the Full Article on Cardiology in Review
Stay updated on all scientific advances with Hemostasis Today.
-
Sep 20, 2026, 06:46Neeraj Songara: From Donated Blood to Engineered Therapeutics
-
Sep 20, 2026, 06:24Louise St. Germain Bannon: Improving Awareness and Care for Women Across the Lifespan
-
Sep 20, 2026, 05:17Maxime Dely: When ABO Compatibility Isn’t Enough for Safe Transfusion
-
Sep 20, 2026, 04:54William Aird: What Does a Complete History and Physical Really Mean?
-
Sep 20, 2026, 04:34Hons Saurabh Kaushik: Why Uncontrolled LDL Can Be Harmful
-
Sep 20, 2026, 03:58Salih Ehsan: The Complexities of HbF and HbA2
-
Sep 20, 2026, 03:22The Voices of People Living With Bleeding Disorders – EHC
-
Sep 20, 2026, 01:18Sebastian Mafeld: Has 2026 Changed How We Treat Pulmonary Embolism?
-
Sep 20, 2026, 01:16Pall T. Onundarson: DOACs – Monitoring, Tailoring Dose and Identifying Problems